Pacific Biosciences of California, Inc. Share Price Today: Live Updates & Key Insights

Pacific Biosciences of California, Inc. share price today is $1.35, up -5%. The stock opened at $1.38 against the previous close of $1.4, with an intraday high of $1.395 and low of $1.315.

Pacific Biosciences of California, Inc. Share Price Chart

Pacific Biosciences of California, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Pacific Biosciences of California, Inc. Share Price Performance

$1.35 -0.05(-5%) PACB at 23 Mar 2026 02:39 PM Medical Devices
Lowest Today 1.315
Highest Today 1.395
Today’s Open 1.38
Prev. Close 1.4
52 Week High 2.73
52 Week Low 0.85
Day’s Range: Low 1.315 High 1.395
52-Week Range: Low 0.85 High 2.73
1 day return -
1 Week return -2.93
1 month return -16.13
3 month return -27.19
6 month return +3.11
1 year return -
3 year return -85.07
5 year return -96.19
10 year return -

Pacific Biosciences of California, Inc. Institutional Holdings

ARK Investment Management LLC 12.34

BlackRock Inc 7.52

ARK Disruptive Innovation Full Composite 7.07

ARK Innovation ETF 6.93

SoftBank Group Corp 6.77

Vanguard Group Inc 5.64

ARK Genomic Revolution ETF 3.64

ARK Genomic Revolution 3.55

Vanguard Total Stock Mkt Idx Inv 2.97

Sumitomo Mitsui Trust Group Inc 2.87

Amova Asset Management Americas, Inc 2.59

Geode Capital Management, LLC 2.34

iShares Russell 2000 ETF 2.22

State Street Corp 1.96

D. E. Shaw & Co LP 1.47

Millennium Management LLC 1.44

Point72 (DIFC) Ltd 1.41

Casdin Capital, LLC 1.40

Amova ARK Pstv Chg Innovt P JPY Acc 1.30

Renaissance Technologies Corp 1.28

Vanguard Institutional Extnd Mkt Idx Tr 1.10

Citadel Advisors Llc 1.05

Amova ARK Disruptive Innovation A USD 1.00

Two Sigma Investments LLC 0.95

Fidelity Small Cap Index 0.90

Susquehanna International Group, LLP 0.86

Koss-Olinger Consulting, LLC 0.86

Charles Schwab Investment Management Inc 0.82

iShares Russell 2000 Value ETF 0.78

Northern Trust Corp 0.76

iShares Biotechnology ETF 0.67

Davy Asset Management Limited 0.63

State St Russell Sm/Mid Cp® Indx SL Cl I 0.54

Fidelity Extended Market Index 0.53

Schwab US Small-Cap ETF™ 0.48

Vanguard Russell 2000 ETF 0.44

Invesco RAFI US 1500 Small-Mid ETF 0.42

ARK Venture D 0.37

Nuveen Quant Small/Mid Cap Eq R6 0.32

State St Russell Sm Cap® Indx SL Cl I 0.31

Pacific Biosciences of California, Inc. Market Status

Strong Buy: 5

Buy: 1

Hold: 8

Sell: 0

Strong Sell: 0

Pacific Biosciences of California, Inc. Fundamentals

Market Cap 401.66 M

PB Ratio 74.5257

PE Ratio 0.0

Enterprise Value 821.55 M

Total Assets 784.08 M

Volume 5469313

Pacific Biosciences of California, Inc. Company Financials

Annual Revenue FY25:160005000 160.0M, FY24:154014000 154.0M, FY23:169517000 169.5M, FY22:128304000 128.3M, FY21:130513000 130.5M

Annual Profit FY25:50674000 50.7M, FY24:37282000 37.3M, FY23:48349000 48.3M, FY22:49035000 49.0M, FY21:58860000 58.9M

Annual Net worth FY25:-546376000 -546.4M, FY24:-308651000 -308.7M, FY23:-309101000 -309.1M, FY22:-296930000 -296.9M, FY21:-181223000 -181.2M

Quarterly Revenue Q4/2025:44645000 44.6M, Q3/2025:38441000 38.4M, Q2/2025:39766000 39.8M, Q1/2025:37153000 37.2M, Q4/2024:39224000 39.2M

Quarterly Profit Q4/2025:16748999 16.7M, Q3/2025:15068000 15.1M, Q2/2025:14684000 14.7M, Q1/2025:-1371000 -1.4M, Q4/2024:10058000 10.1M

Quarterly Net worth Q4/2025:-40371000 -40.4M, Q3/2025:-38000000 -38.0M, Q2/2025:-41930000 -41.9M, Q1/2025:-426075000 -426.1M, Q4/2024:3571000 3.6M

About Pacific Biosciences of California, Inc. & investment objective

Company Information Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, the company provides Revio, Vega, and Sequel instruments which conduct, monitor, and analyze single-molecule biochemical reactions on SMRT cell microchips; short-read sequencing; and onso instrument. It serves academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations, pharmaceutical companies, and agricultural companies. The company markets its products through a sales force and distribution partners in Australia, certain parts of Asia, Europe, the Middle East, Africa, Central America, and South America. It has a collaboration with DNAstack Inc. to provide federated dataset of HiFi whole genome sequencing data. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Organisation Medical Devices

Employees 485

Industry Medical Devices

CEO Mr. Christian O. Henry M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Pacific Biosciences of California, Inc. FAQs

What is the share price of Pacific Biosciences of California, Inc. today?

The current share price of Pacific Biosciences of California, Inc. is $1.35.

Can I buy Pacific Biosciences of California, Inc. shares in India?

Yes, Indian investors can buy Pacific Biosciences of California, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Pacific Biosciences of California, Inc. shares in India?

You can easily invest in Pacific Biosciences of California, Inc. shares from India by:

Can I buy fractional shares of Pacific Biosciences of California, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Pacific Biosciences of California, Inc.?

Pacific Biosciences of California, Inc. has a market cap of $401.66 M.

In which sector does Pacific Biosciences of California, Inc. belong?

Pacific Biosciences of California, Inc. operates in the Medical Devices sector.

What documents are required to invest in Pacific Biosciences of California, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Pacific Biosciences of California, Inc.?

The PE ratio of Pacific Biosciences of California, Inc. is N/A and the PB ratio is 74.53.